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Rheumatoid arthritis (RA) has been related to an impairment of the nutritional status. Body mass index (BMI) has been used but questions
arise about how to properly evaluate nutritional status in RA patients. Few studies have evaluated it by dual-energy X-ray absorptiometry.
In women with RA, to analyze:
(1) their nutritional status compared to that of a control population,
(2) differences between the prevalence of impairment of nutritional status measured by dual energy X ray absorptiometry (DXA)
and by classical methods used in clinical care,
(3) determinants of nutritional status,
(4) prevalence of sarcopenia.














ttp://rheumatic disorders. Study variables included age, RA duration, history, activity and disability, and in relation to nutritional status:
BMI, serum albumin (ALB), whole body DXA assessment, and skeletal muscle index (SMI).
Mean age of patients was 62±8 years, mean duration of RA was 14±9 years, mean disease activity score (DAS28) was 3.7±1.4
and mean Health Assessment Questionnaire was 0.88±0.77. BMI was 27.43±5.16Kg/m2 in patients and 27.78±3.98Kg/m2 in
controls (P: ns). ALB was within normal range in all patients.
By whole body DXA, RA patients presented a statistically significant lower leanmass in all locations and lower fat mass in limbs than
controls. Patients had a redistribution of fat mass to trunk. Lean mass directly correlated with fat mass.
Neither BMI nor ALB correlated with DXA parameters.
BMI, appendicular lean mass and SMI correlated inversely with disease duration. Trunk lean mass correlated inversely, and fat
mass directly, with RA disability parameters.
RA patients fulfilled criteria of sarcopenia in 44% of cases versus 19% of controls (P <.001). In RA patients, regarding SMI, BMI
showed a high specificity to detect sarcopenia (94% of the patients with low BMI had sarcopenia) but low sensitivity (47% of the
patients with normal BMI or overweight had sarcopenia).
RA patients have an impairment of nutritional status associated to disease duration that looks like sarcopenia and that is not
predicted by BMI.
Abbreviations: ACPA = anti-citrullinated protein antibodies, ALB = albumin, BMI = body mass index, DXA = dual-energy X-ray
absorptiometry, MAC = midarm muscular circumference, RA = rheumatoid arthritis, SMI = skeletal muscle index, TSF = triceps
skinfold, WBC = whole body composition.
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Rheumatoid arthritis (RA) is a chronic inflammatory process that
involves the joints. It is the most common type of inflammatory
arthritis in adults, affecting 0.5% [0.3–0.9] of the population in
Spain[1] and has been an important cause of disability and
premature mortality.
RA has been related to an impairment of the nutritional status
of multifactorial etiology. The old term “rheumatoid cachexia”
originally described by James Paget in the 19th century[2] and
representative of a severe degree of malnutrition is nowadays
almost in disuse. The tight control of inflammatory activity in the
treat to target strategy applied currently in RA patients avoids the
appearance of an evident nutritional impairment. However, the
Reina et al. Medicine (2019) 98:6 Medicinenutritional impairment in rheumatic patients is still now a
relevant comorbidity that we have to consider.
Nutritional status is the result of the balance between the
dietary supply and the nutritional requirements necessary to go
on with physiological activities, to compensate losses and to
maintain reserves. Nutritional status is a good predictor of
health.[3] Many efforts have been made to diagnose malnutri-
tion,[4] nevertheless there is no unequivocal definition. It is
generally accepted that it results in a redistribution of fat tissue,
muscle mass and the appearance of hipoproteinemia.
Traditionally, antropometrical measurements, and biochemi-
cal parameters have been used to evaluate malnutrition.
There are several anthropometric methods for the study of the
composition and quantification of body fat and muscle mass. The
most commonly used are body mass index (BMI), midarm
muscular circumference (MAC)[5] and triceps skinfold (TSF)[6]; it
is generally accepted that BMI and TSF basically evaluate fat
mass and MAC evaluates skeletal appendicular muscle mass.
Historically, biochemical evaluation for the assessment of the
nutritional status had included serum proteins such as albumin
(ALB), a protein that reflects the severity and the prognosis of
malnutrition.[7] No other biomarker has proved superiority over
ALB for the evaluation of nutritional status.[8]
Bioelectrical impedance has also been used for the assessment
of the nutritional status.[9] It is based on the application of an
electric current of low potential and intensity at different
frequencies that are transmitted in a different way through lean
and adipose tissues. It is useful for determining the fat-free mass.
Finally, there is a growing consensus[10] that whole body
composition (WBC) analysis by dual-energy X-ray absorptiome-
try (DXA) is the gold standard to evaluate nutritional status.
DXA measures body composition with great reproducibility and
is sensitive to small changes. While different studies have
generated curves that can be used as reference for different
populations,[11] there is still a lot of work to do in this area to
determine universal cutoff points for healthy people.
There are very few data in the literature about nutritional
status measured by DXA in RA patients. In this study, we have
analysed the WBC by DXA in a group of Spanish patients with
RA in order to improve the knowledge in this area.
2. Patients and methods
2.1. Study design
An observational case–control study was carried out.
2.2. Subjects recruitment
The study included women diagnosed with RA (along with 1987
ACR criteria),[12] and most of them fulfilled also ACR 2010
criteria.[13] Patients were recruited consecutively as they were
routinely visited from the outpatient clinics in the rheumatology
service of a university tertiary hospital inwhich around900RAare
regularly evaluated. At inclusion, none of the patients had been
recently hospitalizedby aflare of the disease. Selectedpatientswere
not affected by any potentially consuming disease as neoplasms,
cardiac or respiratory insufficiency or chronic liver or kidney
diseases, and also other debilitating disorders such as VIH, eating
disorders, or psychiatric disorders were excluded. Controls were
recruited, age-matched to patients, consecutively, from the
outpatient clinics during the same period of time. They were
women with mild soft tissue rheumatism as tendonitis or
osteoarthritis; the exclusion criteria were the same as in patients.2
All patients and controls belonged to the same geographical area
and came from a similar social status. The recruitment period took
6 months. All patients and controls gave their oral consent to
participate in the studyand the local evaluating committee gave the
conformity for it, which means that an official and a written
approval from the local Institutional Review Board was obtained.
3. Study variables
All the evaluations were made simultaneously.
3.1. Sociodemographic data and RA evaluation Sociodemographic data: date at birth
Evaluation of:(1) RA history: date at onset, disease duration, rheumatoid factor
(RF) and anti-citrullinated protein antibodies (ACPA),
RA activity: tender joint count (TJC), swollen joint count(2)
(SJC), visual analog scale (VAS), erythrocyte sedimentation
rate (ESR), C-reactive protein (CRP), and disease activity
score (DAS28), and
RA disability: Health Assessment Questionnaire (HAQ).(3)3.2. Nutritional status assessment Anthropometric data: BMI was calculated in both patients and
controls. BMI is the ratio of human body weight to squared
height expressed in kg/m2. It has been categorized as follows:
<18.5kg/m2 is considered underweight; from 18.5 to 25kg/m2,
normal range; from 25 to 30kg/m2, overweight or moderately
obese; and >30kg/m2, severely obese.
Biochemical data: serum ALB was determined only in patients.
 WBC by DXA assessment was determined in patients and
controls.
The examinations were made with a densitometer Hologic
QDR 4500 (Hologic Inc, Bedford, MA), recording fat and lean
mass in arms, trunk, and legs. Quality controls are made
weekly with a step phantom to guarantee the proper
functioning of the technique. The estimated room occupancy
time for a single exam is 8 to 10 minutes. This includes patient
placement, image acquisition and generation of the analysis.
The patient is placed supine, centerd at the table with arms
stretched to the sides of the body, hands looking at the legs
without touching them and the thumbs upwards.
Skeletal muscle index (SMI) was calculated in patients and
controls to measure sarcopenia. SMI is established by the
formula: appendicular skeletal muscle mass/height2. According
to Jannsen et al,[14] sarcopenia is defined as a relative SMI
5.75Kg/m2 in women and <8.50Kg/m2 in men.
4. Statistical analysis
To calculate the sample number, we considered the incidence of
undernutrition in our general population and the calculated risk
of undernutrition in RA patients (from the study of Helliwell
et al).[15] Accepting an alfa risk of 0.05 and a beta risk of 0, the
sample needed was 80 patients per arm.
All the results were recorded in an Access 2003 database. The
statistical software package used was Windows SPSS 15.0.
The results are presented as absolute numbers (percentage) or
as mean± standard deviation. Differences between groups were
Table 1
Clinical characteristics of RA patients (n: 89).
Disease duration (years) 13.7±9.5 (1–42)
RF positive 65 (73%)
ACPA positive 66 (75%)
TJC 4.2±6.3 (0–28)
SJC 1.2±2.2 (0–10)
VAS general health patient 48.4±25.9 (0–100)
ESR, mm/h 24.24±15.65 (3–103)
CRP, mg/L 8.25±10.96 (0.2–83)
DAS28 3.7±1.39 (1.5–6.7)
<2.6 (remission) 21 (24%)
2.6-3.2 (low activity disease) 11 (12%)
>3.2 (moderate activity disease) 37 (41%)
>5.1 (high activity disease) 20 (23%)
HAQ 0.88±0.74 (0–2.75)
ACPA=anti-citrullinated peptide antibodies, CRP=C-reactive protein, DAS28=disease activity
score, ESR= erithrocyte sedimentation rate, HAQ=health assessment questionnaire, RA=
rheumatoid arthritis, RF= rheumatoid factor, SJC= swollen joint count, TJC= tender joint count,
VAS= visual analogue scale.
Reina et al. Medicine (2019) 98:6 www.md-journal.comcalculated by JI squared or analysis of variance. Spearman
correlations were calculated where indicated. Statistical signifi-
cance was established at P< .05.5. Results
Eighty-nine patients and 100 controls were included in the study.
Mean age of the patients was 62±8 years without differences
with controls (64±9 years). The clinical characteristics of the
patients are shown in Table 1. Most patients were seropositiveTable 2
Assessment of nutritional status in RA patients and controls.







>30, severely obese 23%
ALB, g/dL 40.44±4 (28–48)
Fat left arm 2117±899
Fat right arm 2434±1187
Fat arms 4552±2036
Fat trunk 12016±3793
Fat left leg 3962±1303




Lean left arm 1641±360
Lean right arm 1911±455
Lean arms 3552±761
Lean trunk 18966±2505
Lean left leg 5277±897





ALB= albumin, BMI=body mass index, RA= rheumatoid arthritis, SMI= skeletal muscle index.
3
regarding RF and ACPA and had a moderate activity of the
disease.
The results of nutritional assessment are detailed in Table 2.
BMI was 27.43±5.16Kg/m2 in the patients and 27.78±3.98Kg/
m2 in controls (P: ns). Eight percent of the patients versus 18% of
controls were underweighted (P <.05).
All RA patients had normal levels of serum ALB. Whole body
DXA results showed a decrease of lean mass in all locations and a
decrease of fat mass in limbs in RA patients. Fat mass
redistributed to trunk (P <.01) in RA patients although absolute
trunk fat mass was not different between patients and controls.
Forty-four percent of the patients with RA and 19% of the
controls had sarcopenia (P <.001).
BMI was very specific to detect sarcopenia in patients with RA
(94% of patients with low BMI had sarcopenia), but not very
sensitive (47% of patients with normal BMI or overweight had
sarcopenia).
There were more patients than controls with sarcopenia
evaluated by SMI, and the overweight subgroup assessed by BMI
was significantly higher in patients than in controls. This group
could correspond to patients with sarcopenic obesity.
In Table 3, we present the correlations between nutritional and
RA variables. Appendicular lean mass and SMI correlated
inversely with disease duration. Trunk lean mass correlated
inversely, and fat mass directly, with RA disability parameters.6. Discussion
In this study, we have analyzed by DXA the nutritional status of a
group of Spanish women with RA representative of the RA





























Correlations between nutritional and RA variables in RA patients.
Lean extremities Lean trunk Fat extremities Fat trunk BMI ALB SMI
Age ns ns ns r: 0.20
P <.05
ns ns Ns
Disease duration r: -0.27
P <.05
ns ns ns ns ns r: -0.27
P <.05







ns ns ns ns Ns










CRP ns ns ns ns ns ns Ns
ESR ns ns ns ns ns r: -0.37
P <.05
Ns
VAS ns ns ns ns ns ns ns
DAS28 ns ns ns ns ns ns ns
ALB= serum albumin, BMI=body mass index, CRP=C-reactive protein, DAS28=disease activity score, ESR=erythrocyte sedimentation rate, HAQ=health assessment questionnaire, SJC= swollen joint
count, SMI= skeletal muscle index, TJC= tender joint count, VAS= visual analogue scale.
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in all locations and fat mass in limbs with a redistribution of fat
mass to trunk. The assessment of BMI or ALB was not useful to
detect these alterations.
RA is a chronic disease characterized by a high inflammatory
burden. Inflammation, secondary to an excess of production of
inflammatory cytokines as tumor necrosis factor-alpha, inter-
leukins 1 and 6 and others, accelerates protein catabolism. While
the recent and widespread use of more effective therapies and a
tight control of inflammation in RA have nearly extinguished
rheumatoid cachexia, some degree of impairment of nutritional
status is still present in RA patients and more studies are needed
to address the problem.[16,17]
In our study, we have found that RA disability is inversely
correlated to lean mass and directly to fat trunk; also, that RA
time of evolution correlates inversely with lean mass in limbs and
SMI. More long and aggressive disease provokes a loss of muscle
mass. In our cohort, we did not find correlation between
inflammatory activity and nutritional parameters, but this is not
contradictory because, in cross-sectional studies, parameters of
inflammation represent a punctual moment and nutritional
status, the burden of years of disease.
Rheumatoid cachexia or its current equivalent to a much lesser
degree, loss of lean body mass, is under-recognized in clinical
practice. Usually, it runs in parallel with an increased body fat
mass, resulting in a normal BMI.[18] This also involves an under-
diagnosis of obesity when using the traditional values of BMI in
well controlled RA patients, compared to DXA parameters.[19]
Stravroupulos-Kalinoglu et al pointed out that BMI could be an
inexact tool to categorize the nutritional status in RA and that the
standard cut-offs point should be modified.[20] In the same sense,
we have found that they don’t always detect sarcopenia: BMI was
very specific but not very sensitive to detect sarcopenia in patients
with RA.
We found that controls and patients had globally a similar
BMI, but comparing the subgroups there were remarkable
differences in this nutritional parameter in the underweight and
the overweight groups: controls had more underweight than RA
patients (8% in RA, 18% in controls) and RA patients had more
overweight than controls (54% in RA, 33% in controls).
In a previous study of our group, hypoalbuminemia was
present and closely related to RA activity parameters,[21] but this4
was only seen in the patients with worse functionality and BMI, it
does not seem useful in patients without clear clinical malnutri-
tion.
Studies in the literature on nutritional status in RA are
heterogeneous. The majority of them only measure either
anthropometric or biochemical parameters, and very few assess
whole body DXA. Furthermore, lately, they are centered more in
obesity as an additional cardiovascular risk factor for RA patients
or as a contributor, through the production of proinflammatory
adipokines, to disease severity than in undernutrition.
Elkan et al evaluated body composition and nutritional status
using DXA and bioelectrical impedance in 80 patients with RA
(they were about 60 years old and had a mean disease duration of
6 years) and concluded that rheumatoid cachexia and central
obesity were common by DXA and bioelectrical impedance and
that BMI was unable to detect them. Cachexia, defined as fat-free
mass index below the 25th percentile and fat mass index above
the 50th percentile of a reference population, was not related to
diet fat intake, but associated with high levels of LDL cholesterol
and a high frequency of hypertension.[22]
Popescu et al found that 107 RA women (they were about 56
years old and had a mean disease duration of 10 years) had a
higher prevalence of normal weight obesity than controls.
Disease duration and severity were associated with higher whole
body and regional adiposity.[23]
In a recent review[24] in search of an association between
obesity and RA activity, in 6 of 11 studies there was a significant
direct correlation between clinical activity and BMI. The studies
did not provide enough data to assess the relationship between
body composition and clinical activity. In the only study in which
DXA was used, the analysis was centered in obesity and
associated cardiovascular risk.[25]
Ngeuleu et al evaluated the prevalence of sarcopenia (defined
as a SMI <5.5Kg/m2 in women) in 123 patients with RA and the
influence of sarcopenia on disease activity. Sarcopenia was
prevalent and related to age, bone erosion, normal or overweight
BMI, and high cardiometabolic risk according to waist
circumference but not with disease activity.[26]
Rheumatologist may need to assess nutritional status among
other comorbidities in RA patients because chronic inflammation
increases the metabolic index and nutritional requirements.
When malnutrition is clinically evident is very difficult to correct
[8] Fogelholm M, van Marken Lichtenbelt W. Comparison of body
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early diagnose, obviously the sooner we can make the diagnosis,
the better we can apply therapeutic strategies. Nevertheless,
nowadays, is not common to see a high chronic inflammatory
state that provokes an evident malnutrition in RA patients.
Hence, the identification of mild impairment of nutritional status
could be beneficial to avoid proinflammatory state associated to
obesity and to reduce cardiovascular risk associated to RA,
obesity, and sarcopenia.
A clear weakness of the study is that we did not analyzed how
the different treatments that RA patients were receiving (as
glucocorticoids or biological therapies) could have influenced in
the nutritional status. Likewise, another weakness is the absence
of an analysis of the exercise that both groups in the study were
doing.
The usual methods used to evaluate nutritional status do not
seem to be always suitable in RA patients: more specific measures
of lean mass like whole body DXA are needed. Simple
identification of patients eligible for DXA analysis is still needed
to improve cost-effectiveness. Although measurement of body
composition using DXA is clearly feasible, more studies are
needed to fully understand the clinical benefits of this technique.
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